Commonwealth Equity Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,176
Closed -$980K 3762
2021
Q4
$980K Buy
10,176
+7,704
+312% +$742K ﹤0.01% 2003
2021
Q3
$214K Hold
2,472
﹤0.01% 3220
2021
Q2
$202K Sell
2,472
-46
-2% -$3.76K ﹤0.01% 3256
2021
Q1
$239K Buy
+2,518
New +$239K ﹤0.01% 2979
2020
Q4
Sell
-3,924
Closed -$233K 3237
2020
Q3
$233K Buy
3,924
+133
+4% +$7.9K ﹤0.01% 2581
2020
Q2
$264K Buy
+3,791
New +$264K ﹤0.01% 2373
2020
Q1
Sell
-3,350
Closed -$217K 2902
2019
Q4
$217K Sell
3,350
-826
-20% -$53.5K ﹤0.01% 2556
2019
Q3
$259K Sell
4,176
-3,857
-48% -$239K ﹤0.01% 2363
2019
Q2
$572K Buy
8,033
+1,866
+30% +$133K ﹤0.01% 1703
2019
Q1
$483K Buy
+6,167
New +$483K ﹤0.01% 1782
2018
Q4
Sell
-2,558
Closed -$438K 2765
2018
Q3
$438K Buy
2,558
+878
+52% +$150K ﹤0.01% 1875
2018
Q2
$217K Sell
1,680
-258
-13% -$33.3K ﹤0.01% 2392
2018
Q1
$199K Sell
1,938
-462
-19% -$47.4K ﹤0.01% 2413
2017
Q4
$205K Sell
2,400
-258
-10% -$22K ﹤0.01% 2351
2017
Q3
$226K Hold
2,658
﹤0.01% 2185
2017
Q2
$201K Buy
+2,658
New +$201K ﹤0.01% 2229
2017
Q1
Sell
-7,502
Closed -$476K 2449
2016
Q4
$476K Buy
7,502
+1,529
+26% +$97K ﹤0.01% 1433
2016
Q3
$380K Sell
5,973
-872
-13% -$55.5K ﹤0.01% 1551
2016
Q2
$509K Sell
6,845
-2,787
-29% -$207K ﹤0.01% 1347
2016
Q1
$644K Sell
9,632
-106
-1% -$7.09K 0.01% 1178
2015
Q4
$659K Buy
9,738
+3,239
+50% +$219K 0.01% 1140
2015
Q3
$347K Buy
6,499
+3,247
+100% +$173K ﹤0.01% 1467
2015
Q2
$205K Sell
3,252
-2,301
-41% -$145K ﹤0.01% 1909
2015
Q1
$267K Sell
5,553
-4,679
-46% -$225K ﹤0.01% 1714
2014
Q4
$340K Sell
10,232
-321
-3% -$10.7K ﹤0.01% 1485
2014
Q3
$309K Buy
+10,553
New +$309K ﹤0.01% 1532